Development and evaluation of an improved method for screening of amphetamines

Journal of Analytical Toxicology

Volumn 23, Issue 6, 1999, Pages 506-510

  Shindelman, J ^a   Mahal, J ^a,d   Hemphill, G ^b   Pizzo, P ^c   Coty, W A ^a  

^a Microgenics Corporation   (United States)

^b MEDTOX Laboratories   (United States)

^c Laboratory Specialists   (United States)

^d Bio Spectrum   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; METHAMPHETAMINE; NEUTRALIZING ANTIBODY; NON PRESCRIPTION DRUG;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG SCREENING; DRUG SYNTHESIS; FLUORESCENCE POLARIZATION IMMUNOASSAY; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; URINALYSIS;

EID: 0032845144     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/23.6.506     Document Type: Article

References (11)

1. J. D'Nicuola, R. Jones, B. Levine, and M.L. Smith. Evaluation of six commerical amphetamines and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. J. Anal. Toxicol. 16: 211-213 (1992).
2. Behring Diagnostics Inc. Technical package insert for EMIT Monoclonal Amphetamine/Methamphetamine, March 1997.
3. Boehringer Mannheim Corp. Technical package insert for CEDIA DAU Amphetamines, September 1997.
4. Abbott Laboratories. Technical package insert for TDx Amphetamine/Methamphetamine II, January 1996.
5. W. Markus. Annual workload questionnaire expands to include more drugs. Forensic Urine Drug Testing (Sept): 2-3 (1993).
6. A. Castro, D. Grettle, F. Bartos, and D. Bartos. LSD radioimmunoassay. Res. Comm. Chem. Path. Pharm. 6(3): 879-886 (1973).
7. W. Ratcliffe, S. Fletcher, A. Moffat, J. Ratcliffe, W. Harland, and T. Levitt. Radioimmunoassay of lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specificities. Clin. Chem. 23(2): 169-174 (1977).
8. W. Wahba, C. Winek, and L. Rozin. Elimination of ephedrine cross-reactivity in the Coat-A-Count methamphetamine radioimmunoassay. J. Anal. Toxicol. 17: 125-126 (1993).
9. V. Spiehler, H. Wilson, K. Pregger, and R. Harris. Elimination of interferences from ephedrine and related compounds in Coat-A-Count methamphetamine radioimmunoassay. Clin. Chem. 39: 172-173 (1993).
10. B. Paul, M. Past, R. McKinley, J. Foreman, L. McWhorter, and J. Snyder. Amphetamine as an artifact of methamphetamine during periodate degradation of interfering ephedrine, pseudoephedrine, and phenylpropanolamine: an improved procedure for accurate quantitation of amphetamines in urine. J. Anal. Toxicol. 18: 331-336 (1994).
11. E. Thurman, M. Pedersen, R. Stout, and T. Martin. Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry. J. Anal. Toxicol. 16: 19-27 (1992).